Wang X - Search Results

1

Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer.

Huang L, Qiao G, Morse MA, Wang X, Zhou X, Wu J, Hobeika A, Ren J, Lyerly HK. Huang L, et al. Among authors: wang x. Oncol Lett. 2019 Dec;18(6):5717-5724. doi: 10.3892/ol.2019.10964. Epub 2019 Oct 4. Oncol Lett. 2019. PMID: 31788044 Free PMC article.

2

Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patients.

Zhou X, Qiao G, Ren J, Wang X, Wang S, Zhu S, Yuan Y, Morse MA, Hobeika A, Lyerly HK. Zhou X, et al. Among authors: wang x, wang s. Pain. 2020 Jan;161(1):127-134. doi: 10.1097/j.pain.0000000000001702. Pain. 2020. PMID: 31568023

3

Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors.

Qiao G, Wang X, Zhou X, Morse MA, Wu J, Wang S, Song Y, Jiang N, Zhao Y, Zhou L, Zhao J, Di Y, Zhu L, Hobeika A, Ren J, Lyerly HK. Qiao G, et al. Among authors: wang x, wang s. Int J Hyperthermia. 2019 Nov;36(sup1):74-82. doi: 10.1080/02656736.2019.1647350. Int J Hyperthermia. 2019. PMID: 31795830 Free article. Clinical Trial.

4

Serial assessment of circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapy.

Wang X, Qiao G, Jiang N, Morse MA, Zhou X, Wang S, Wu J, Song Y, Zhao Y, Zhou L, Yuan Y, Hobeika A, Ren J, Lyerly HK. Wang X, et al. Among authors: wang s. Am J Cancer Res. 2021 Apr 15;11(4):1709-1718. eCollection 2021. Am J Cancer Res. 2021. PMID: 33948384 Free PMC article.

5

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy.

Yang D, Wang X, Zhou X, Zhao J, Yang H, Wang S, Morse MA, Wu J, Yuan Y, Li S, Hobeika A, Lyerly HK, Ren J. Yang D, et al. Among authors: wang x, wang s. Oncoimmunology. 2021 Sep 27;10(1):1976953. doi: 10.1080/2162402X.2021.1976953. eCollection 2021. Oncoimmunology. 2021. PMID: 34595059 Free PMC article.

6

Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments.

Zhao YJ, Jiang N, Song QK, Wu JP, Song YG, Zhang HM, Chen F, Zhou L, Wang XL, Zhou XN, Yang HB, Ren J, Lyerly HK. Zhao YJ, et al. Asian Pac J Cancer Prev. 2015;16(6):2419-23. doi: 10.7314/apjcp.2015.16.6.2419. Asian Pac J Cancer Prev. 2015. PMID: 25824775 Free article.

7

Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.

Song QK, Wang XL, Zhou XN, Yang HB, Li YC, Wu JP, Ren J, Lyerly HK. Song QK, et al. Oncologist. 2015 Jul;20(7):773-9. doi: 10.1634/theoncologist.2014-0351. Epub 2015 May 22. Oncologist. 2015. PMID: 26001390 Free PMC article.

8

The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.

Song QK, Ren J, Zhou XN, Wang XL, Song GH, Di LJ, Yu J, Hobeika A, Morse MA, Yuan YH, Yang HB, Lyerly HK. Song QK, et al. Oncotarget. 2015 Dec 1;6(38):41350-9. doi: 10.18632/oncotarget.5534. Oncotarget. 2015. PMID: 26462021 Free PMC article.

9

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.

Ren J, Gwin WR, Zhou X, Wang X, Huang H, Jiang N, Zhou L, Agarwal P, Hobeika A, Crosby E, Hartman ZC, Morse MA, H Eng K, Lyerly HK. Ren J, et al. Among authors: wang x. Oncoimmunology. 2016 Dec 7;6(4):e1264563. doi: 10.1080/2162402X.2016.1264563. eCollection 2017. Oncoimmunology. 2016. PMID: 28507788 Free PMC article.

10

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.

Jiang N, Qiao G, Wang X, Morse MA, Gwin WR, Zhou L, Song Y, Zhao Y, Chen F, Zhou X, Huang L, Hobeika A, Yi X, Xia X, Guan Y, Song J, Ren J, Lyerly HK. Jiang N, et al. Among authors: wang x. Clin Cancer Res. 2017 Sep 1;23(17):5066-5073. doi: 10.1158/1078-0432.CCR-17-0492. Epub 2017 Jun 13. Clin Cancer Res. 2017. PMID: 28611200 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,989 results

Search Page

Filters